Skip to main content

FASEB moves from bench to bedside

Next executive director embodies shift in organization's direction.

Written byEmma Hitt
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00

SAN DIEGO — A medical doctor rather than a bench researcher has been selected as the new Executive Director of the Federation of American Societies for Experimental Biology (FASEB), the world's largest organization of basic research scientists. According to Frederick R. Rickles, professor of medicine and pediatrics at George Washington University, his appointment highlights FASEB's shift in recent years toward translational, or "bench-to-bedside," research, although the focus of the organization stops short of being purely clinical, he said.

"FASEB used to be viewed as a society that focused primarily on basic research," explained Rickles, "but with the inclusion of societies such as the American Society of Clinical Investigation and others, the research focus has expanded. My selection for the position of executive director is perhaps a logical progression representing that shift."

FASEB's 60,000 members are drawn from 14 member societies and eight associate societies, making it the largest coalition of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related Topics

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo